OTC · OSAPQ
Healthcare · Medical - Devices
$0.01
Up+$0.00 (+2.94%)
Updated Aug 25, 2026, 4:12 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
OSAPQ does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning OSAPQ.
OSAPQ research
Company profile and research snapshot.
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California. On May 7, 2024, ProSomnus, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Finnhub · Apr 13, 2026
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration has granted Class II 510 clearance for its RPMO2 OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG . The...
Finnhub · Apr 13, 2026
SAN FRANCISCO, April 13, 2026 -- ProSomnus Sleep Technologies , the leading non-CPAP Obstructive Sleep Apnea therapy® and pioneer in Smart Sleep Medicine™, today announced that the U.S. Food...
GlobeNewswire Inc. · May 30, 2024
ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024
GlobeNewswire Inc. · May 16, 2024
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning OSAPQ.
No results
No recent SID articles mention OSAPQ.
